| |
| |
|
| Insider
Information: |
Shanmugam Muthusamy |
| Relationship: |
HEAD OF R&D, COO-NOVIT... |
| City: |
Baudette |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
68,652 |
|
|
Indirect Shares
|
737,620 |
|
|
| Direct
Value |
$4,616,847 |
|
|
|
Indirect Value
|
$49,604,945 |
|
|
| Total
Shares |
806,272 |
|
|
| Total
Value |
$54,221,792 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ANI Pharmaceuticals Inc |
ANIP |
HEAD OF R&D, COO-NOVIT... |
2024-05-20 |
68,652 |
2024-05-20 |
737,620 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF R&D, COO-NOVITIUM OPS |
• • – |
2024-05-16 |
4 |
AS |
$63.84 |
$1,050,743 |
I/I |
(16,459) |
751,311 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF R&D, COO-NOVITIUM OPS |
• • – |
2024-05-17 |
4 |
AS |
$62.09 |
$362,357 |
I/I |
(5,836) |
745,475 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF R&D, COO-NOVITIUM OPS |
• • – |
2024-05-20 |
4 |
AS |
$61.81 |
$794,568 |
I/I |
(12,855) |
732,620 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF R&D, COO-NOVITIUM OPS |
• • – |
2022-03-17 |
4 |
B |
$27.65 |
$138,252 |
I/I |
5,000 |
5,000 |
0.01 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF R&D, COO-NOVITIUM OPS |
• • – |
2022-03-17 |
4 |
B |
$27.65 |
$138,252 |
D/D |
5,000 |
18,460 |
0.01 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF R&D, COO-NOVITIUM OPS |
• • – |
2024-02-29 |
4 |
D |
$67.67 |
$75,926 |
D/D |
(1,122) |
68,652 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF R&D, COO-NOVITIUM OPS |
• • – |
2023-08-28 |
4 |
S |
$63.06 |
$1,576,500 |
I/I |
(25,000) |
1,157,620 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF R&D, COO-NOVITIUM OPS |
• • – |
2023-08-29 |
4 |
S |
$63.37 |
$1,584,250 |
I/I |
(25,000) |
1,132,620 |
0 |
- |
|
58 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
